Alyeska Investment Group, L.P. Teva Pharmaceutical Industries LTD Transaction History
Alyeska Investment Group, L.P.
- $18 Billion
- Q3 2024
A detailed history of Alyeska Investment Group, L.P. transactions in Teva Pharmaceutical Industries LTD stock. As of the latest transaction made, Alyeska Investment Group, L.P. holds 3,625,000 shares of TEVA stock, worth $78.3 Million. This represents 0.36% of its overall portfolio holdings.
Number of Shares
3,625,000
Previous 3,828,871
5.32%
Holding current value
$78.3 Million
Previous $62.2 Million
4.99%
% of portfolio
0.36%
Previous 0.38%
Shares
6 transactions
Others Institutions Holding TEVA
# of Institutions
626Shares Held
573MCall Options Held
19.6MPut Options Held
6.77M-
Black Rock Inc. New York, NY43MShares$929 Million0.02% of portfolio
-
Ion Asset Management Ltd. George Town, Grand Cayman, E936.2MShares$783 Million35.87% of portfolio
-
Clal Insurance Enterprises Holdings LTD Tel Aviv, L334.5MShares$746 Million5.5% of portfolio
-
Menora Mivtachim Holdings Ltd.28.8MShares$623 Million3.32% of portfolio
-
Exor Capital LLP London, X026.5MShares$572 Million14.79% of portfolio
About TEVA PHARMACEUTICAL INDUSTRIES LTD
- Ticker TEVA
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 1,110,560,000
- Market Cap $24B
- Description
- Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...